NIH clinical center

Director, Drug Information Service, NIH Clinical Center... 

NIH Clinical Center National Institules ot Heallh hnp //www.ec.nih.giH/cce/supple-irieiils/inagn.hmil... 

The second child was a 9-month-old white female admitted to the NIH Clinical Center for evaluation of multiple long-bone fractures. She was born to a 31-year-old mother with a previous spontaneous miscarriage. The patient was the product of a normal pregnancy bom at 38... 

This book is the outgrowth of an evening course that has been taught for the past three years at the NIH Clinical Center. Wherever possible individuals who... 

Clinical Pharmacokinetics Research Lab. NIH Clinical Center Pharmacy Department Bethesda, MD 20892... 

Information regarding clinical trials conducted at the NIH Clinical Center in Bethesda, Maryland, can be found at http //clinicalstudies.info.nih.gov/. ClinicalTrials.gov (http //clinicaltrials.gov) provides information on federal and private medical studies at thousands of locations... 

Publications by NIH Clinical Center clinical oncology pharmacists have received national attention and improve pharmacy practice processes examples include ways to standardize expression and nomenclature of cancer treatment regimens " and pharmacy procedures for dealing with gene therapy products. 

If food management does not lower serum lipids sufficiently, the levels may be decreased further by administration of hypolipidemic drugs. Drug therapy at the NIH clinical center has been outlined by Levy and Fredrickson" and is shown in the following table ... 

At the National Institutes of Health Clinical Center, oncology clinical pharmacists participate as members on the NCI Physician s Data Query online cancer information service supportive care and drug information panels and serve on the Board of Pharmaceutical Specialties Council on Oncology Pharmacy Practice. - These pharmacists, in conjunction with the NIH Division of Safety, developed the first recommendations for safe handling and disposal of antineoplastic drug products and waste. 

One-month clinical trials of Capronor were sponsored by the National Institutes of Health (NIH) at Duke University Medical Center and by... 

From Panel on Clinical Practices for the Treatment of HIV Infection. Treating Opportunistic Infections among HIV-Infected Adults and Adolescents recommendations from Center for Disease Control and Prevention, the National Institutes of Health and the HIV Medicine Association/lnfedious Diseases Society of America. December 17, 2004, http //mm.AIDSinfo.NIH.gov. 

Other important documents in HSTAT include the National Institutes of Health (NIH) Consensus Conference Reports and Technology Assessment Reports the HIV/AIDS Treatment Information Service (ATIS) resource documents the Substance Abuse and Mental Health Services Administration s Center for Substance Abuse Treatment (SAMHSA/CSAT) Treatment Improvement Protocols (TIP) and Center for Substance Abuse Prevention (SAMHSA/CSAP) Prevention Enhancement Protocols System (PEPS) the Public Health Service (PHS) Preventive Services Task Force s Guide to Clinical Preventive Services the independent, nonfederal Task Force on Community Services Guide to Community Preventive Services and the Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) health technology evaluations. 

The NIH and the pharmaceutical industry have formed a new partnership to overcome barriers to early-phase clinical trials. The Secretary of Health and Human Services, Tommy Thompson, announced on July 9, 2003 grant awards for six cancer centers involved in a unique public-private partnership. Five pharmaceutical companies together with NCI put forth a total of 5.7 million for this partnership. Institutions receiving the funding include Massachusetts General Hospital University of Colorado Health Sciences Center Washington University, St. Louis University of Pittsburgh Cancer Institute University of California, Davis Cancer Center and Ohio State University Comprehensive Cancer Center (http //WWW. bms.com/news/other/data/pf other.news.385 5. html). 

In the United States, the National Center of Complementary and Alternative Medicine (NCCAM) was created in 1998 as one of the many research institutes and centers within the prestigious National Institutes of Health (NIH). This government research center collaborates with academic medical centers to evaluate specific nontraditional approaches to health and healing by conducting clinical trials and other scientific studies, as is done for drugs. 

With the support that has been provided since its creation, NCCAM has invested in a broad array of scientific research projects that span the spectrum from basic research, such as interactions between botanical products and conventional drags, to the conduct of clinical trials to study the safety and efficacy of CAM modalities. The NCCAM portfolio also includes support for research training and education grants. In addition, the Center disseminates information through the NCCAM Clearinghouse (info nccam.nih.gov) and the NCCAM website (http //www.nccam.nih.gov). 

---